Secondary Schizophrenia Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Secondary Schizophrenia book. This book definitely worth reading, it is an incredibly well-written.
Secondary Schizophrenia by Perminder S. Sachdev,Matcheri S. Keshavan Pdf
Schizophrenia may not be a single disease, but the result of a diverse set of related conditions. Modern neuroscience is beginning to reveal some of the genetic and environmental underpinnings of schizophrenia; however, an approach less well travelled is to examine the medical disorders that produce symptoms resembling schizophrenia. This book is the first major attempt to bring together the diseases that produce what has been termed 'secondary schizophrenia'. International experts from diverse backgrounds ask the questions: does this medical disorder, or drug, or condition cause psychosis? If yes, does it resemble schizophrenia? What mechanisms form the basis of this relationship? What implications does this understanding have for aetiology and treatment? The answers are a feast for clinicians and researchers of psychosis and schizophrenia. They mark the next step in trying to meet the most important challenge to modern neuroscience – understanding and conquering this most mysterious of human diseases.
This book provides clear and concise guidance for clinicians when they encounter a patient with psychosis, starting with the medical work-up to arrive at a diagnosis and ending with the comprehensive care for patients with established schizophrenia. It covers the optimal use of medications (emphasizing safe use) but also addresses other treatment approaches (psychological treatments, rehabilitation) and the larger societal context of care, including how to work effectively in complex systems. It uniquely condenses the literature into teaching points without simplifying too much, effectively serving as a learning tool for trainees and professionals. For this second edition, the book was extensively updated and its content expanded, with new figures as well. Each chapter begins with an initial summary and includes Tips and Key Points in text boxes. Each chapter also includes links to external websites and additional readings. The book contains clinical and practical wisdom for clinicians who are treating real patients at the front lines, setting it apart from all other texts. Psychotic Disorders is an excellent resource for medical students, early career professionals such as trainees and fellows, and related clinicians seeking additional training and resources, including those in psychiatry, psychology, neurology, and all others.
First Episode Psychosis by Katherine J. Aitchison,Robin M. Murray,Patrick J. Power,Eva M. Tsapakis Pdf
The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. This is an authoritative text written by a team of highly respected authors for psychiatrists, neurologists, primary care practitioners and health care professional working in psychiatry. Drawing from their experience, the presentation and assessment of the first psychotic episode are discussed, details regarding antipsychotic drugs and their appropriate use are reviewed and psychosocial approaches are examined. The resulting book offers a concise and valuable guide to those wishing to review the latest proposals for the treatment of first-episode psychosis supported by up-to-date references, in a single publication.
The American Psychiatric Association Publishing Textbook of Schizophrenia, Second Edition by Jeffrey A. Lieberman, M.D.,T. Scott Stroup, M.D., M.P.H.,Diana O. Perkins, M.D., M.P.H.,Lisa B. Dixon, M.D., M.P.H. Pdf
This is an invaluable single source for the latest scholarship and clinical knowledge about schizophrenia. The book is divided into three parts, addressing the presentation of schizophrenia, the etiology and pathophysiology of the disorder, and treatment and rehabilitative therapies.
Robin M. Murray,Peter B. Jones,Ezra Susser,Jim Van Os,Mary Cannon
Author : Robin M. Murray,Peter B. Jones,Ezra Susser,Jim Van Os,Mary Cannon Publisher : Cambridge University Press Page : 474 pages File Size : 48,9 Mb Release : 2002-11-28 Category : Medical ISBN : 9781139439480
The Epidemiology of Schizophrenia by Robin M. Murray,Peter B. Jones,Ezra Susser,Jim Van Os,Mary Cannon Pdf
An international team of leading researchers and clinicians here provide a comprehensive, epidemiological overview of this multi-faceted and still perplexing disorder, and address some of the key questions it raises. How important in the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia changing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth, and separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered. Drawing together the findings from social, genetic, developmental and classical epidemiology of schizophrenia, this text will prove an invaluable resource for clinicians and researchers.
Schizo-Obsessive Disorder by Michael Poyurovsky Pdf
This is the first book to address the clinical and neurobiological interface between schizophrenia and obsessive-compulsive disorder (OCD). There is growing evidence that obsessive-compulsive symptoms in schizophrenia are prevalent, persistent and characterized by a distinct pattern of familial inheritance, neurocognitive deficits and brain activation. This text provides guidelines for differential diagnosis of schizophrenic patients with obsessive-compulsive symptoms, and patients with primary OCD alongside poor insight, psychotic features or schizotypal personality. Written by a leading expert in the coexistence of obsessive-compulsive and schizophrenic phenomena, Schizo-Obsessive Disorder uses numerous case studies to present diagnostic guidelines and to describe a recommended treatment algorithm, demystifying this complex disorder and aiding its effective management. The book is essential reading for psychiatrists, neurologists and the wider range of multidisciplinary mental health practitioners.
Author : World Health Organization Publisher : World Health Organization Page : 80 pages File Size : 44,7 Mb Release : 2009 Category : Medical ISBN : 9789241547697
Pharmacological Treatment of Mental Disorders in Primary Health Care by World Health Organization Pdf
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Psychosis and Schizophrenia in Children and Young People by National Collaborating Centre for Mental Health (Great Britain) Pdf
These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.
U. S. Department of Health and Human Services,Agency for Healthcare Research and Quality
Author : U. S. Department of Health and Human Services,Agency for Healthcare Research and Quality Publisher : Createspace Independent Pub Page : 570 pages File Size : 53,7 Mb Release : 2013-03-24 Category : Medical ISBN : 1483944239
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness by U. S. Department of Health and Human Services,Agency for Healthcare Research and Quality Pdf
Antipsychotic medications are used to treat and manage symptoms for several psychiatric disorders and are commonly categorized into two classes. First-generation antipsychotics (FGAs), also known as “typical antipsychotics,” were developed in the 1950s. Second-generation antipsychotics (SGAs), also known as “atypical antipsychotics,” emerged in the 1980s. To date, FGAs have been classified according to their chemical structure, which includes serotonin-dopamine antagonists and multiacting receptor-targeted antipsychotics, whereas SGAs have been categorized according to their pharmacological properties as dopamine partial agonists. There is ongoing research testing the proposed mechanisms of action within each class with respect to the neurobiology of different psychiatric disorders. According to findings from the 2004–05 Medical Expenditure Panel Survey, an estimated 2 million adult patients in the U.S. were prescribed an antipsychotic medication, three quarters of whom were taking an SGA. In 2003, an estimated $2.82 billion were spent in the country on these medications, with SGAs accounting for 93% of this expenditure. Today, 20 FGAs and SGAs are commercially available in the U.S. and approved by the FDA. Individuals taking antipsychotics may stop taking their medication for a number of reasons, including adverse events (AEs) and a lack of improvement in their symptoms. As a result, ongoing evaluations of drug efficacy and models of patient decisionmaking are essential. This Review provides a comprehensive synthesis of the evidence examining the benefits and harms associated with the use of FDA-approved FGAs and SGAs. This CER focuses on comparisons of individual medications rather than drug classes. This topic is important and timely, given the ongoing debate about the comparative benefits and harms of FGAs and SGAs. The focus of this report complements other recent reviews investigating different SGAs, the off-label use of antipsychotics, and FGAs versus SGAs in the pediatric population. The focus of this report is adults age 18 to 64 years with schizophrenia, schizophrenia-related psychoses, and bipolar disorder. The following Key Questions were investigated in the report: 1. For adults (age 18 to 64 years) with schizophrenia, schizophrenia-related psychoses, or bipolar disorder, what are the comparative efficacy and effectiveness of FGAs versus SGAs for improving core illness symptoms? 2. For adults (age 18 to 64 years) with schizophrenia, schizophrenia-related psychoses, or bipolar disorder, what is the comparative effectiveness of FGAs versus SGAs for improving functional outcomes and decreasing health care system utilization? 3. For adults (age 18 to 64 years) with schizophrenia, schizophrenia-related psychoses, or bipolar disorder, do FGAs and SGAs differ in medication-associated AEs and safety? 4. For adults (age 18 to 64 years) with schizophrenia, schizophrenia-related psychoses, or bipolar disorder, what is the comparative effectiveness of FGAs versus SGAs for the following other outcomes: Relapse and remission rates, Medication adherence and persistent use, Patient insight into illness, Health-related quality of life, Patient satisfaction, Comorbidity: endpoints of victimization, homelessness, and substance abuse, Patient-reported outcomes, Ability to obtain and retain employment and succeed in job duties, Concomitant use of other medications, especially those used to treat EPS, and Patient preferences. 5. For adults (age 18 to 64 years) with schizophrenia, schizophrenia-related psychoses, or bipolar disorder, what are the comparative effectiveness and risks of FGAs versus SGAs in subgroups defined by the following variables? Disorder subtypes, Sex, Age group (18–35 years, 36–54 years, and 55–64 years), Race, Comorbidities, Drug dosage, Follow up period, Treatment of a first episode versus treatment in the context of previous episodes (previous exposure to antipsychotics), and Treatment resistance.
Author : Steven R. Hirsch,Daniel R. Weinberger Publisher : John Wiley & Sons Page : 766 pages File Size : 51,7 Mb Release : 2008-04-15 Category : Medical ISBN : 9781405140102
Schizophrenia by Steven R. Hirsch,Daniel R. Weinberger Pdf
Schizophrenia is one of the most complex and puzzling diseases toaffect mankind. It is the most common of the severe mentalillnesses (psychoses) with an estimated prevalence of 0.5 - 1% inthe general population and accounts for a very large portion of theday to day workload of the average psychiatrist. 50% of long-termpsychiatric patients in mental hospitals are schizophrenic. There is a great deal of controversy about the causes, diagnosisand treatment of schizophrenia with the consequence that a hugeamount of research is carried out in the field by psychiatrists,psychologists, neuroscientists and pharmacologists. For the averagepractising psychiatrist seeing schizophrenics on a regular basis,making sense of the vast body of information on the subject andfiltering out what is of clinical relevance can be very difficult.There is a constant stream of new drugs emerging and the newergeneration of drugs (the so-called atypicals) is very effective,but often expensive. The Editors (one American and one British) are both highlyrespected clinical psychiatrists who are probably the leadingexperts on schizophrenia from their respective countries andjointly have published almost 150 papers on the subject. They have brought together a strong group of contributors from theUSA, UK and Europe to produce what will be an essential referencefor the trainee and practising psychiatrist. The book consists of four sections; descriptive aspects,causative aspects, physical treatments andpsychological/behavioural/social treatments. There will bediscussion of the theoretical controversies over symptomatology,classification and aetiology, the relationship of schizophrenia tothe other psychoses, the significance of positive and negativesymptoms and pre-morbid personality. There will be chapters onorganic models of schiziophrenia, neurodevelopmental, genetic andstructural studies and the role of high-expressed emotion. Thefinal section will cover social and environmental treatment, therole of the families of schizophrenics and the psychoanalyticaltherapies. There is a new chapter on the patient's perspectivewritten by a former patient.
S. Charles Schulz,Michael F. Green,Katharine J. Nelson
Author : S. Charles Schulz,Michael F. Green,Katharine J. Nelson Publisher : Oxford University Press Page : 424 pages File Size : 47,6 Mb Release : 2016-04-01 Category : Medical ISBN : 9780199378074
Schizophrenia and Psychotic Spectrum Disorders by S. Charles Schulz,Michael F. Green,Katharine J. Nelson Pdf
Schizophrenia and Psychotic Spectrum Disorders aims to engage young caregivers in psychiatry, psychology, nursing and social work so that they will be able to become well informed about this significant--and at times confusing--illness. Because schizophrenia is considered to be one of the most complicated and severe psychiatric disorders, this book has the goal of summarizing key issues of the illness, such as its presentation, frequency and age of onset, and diagnostic characteristics. It also contains informative chapters about the pathophysiology of schizophrenia, ranging from brain development issues, genetics, and likely abnormalities in neurotransmitters. This book will give young professionals and those joining the field an excellent and accessible background to treatment. In this area, Schizophrenia and Psychotic Spectrum Disorders provides a comprehensive approach to diagnosis, treatment initiation, strategies for non-response, approaches of therapy, and importantly, ways to provide family therapy and support.
Robin M. Murray,Kenneth S. Kendler,Peter McGuffin,Simon Wessely,David J. Castle
Author : Robin M. Murray,Kenneth S. Kendler,Peter McGuffin,Simon Wessely,David J. Castle Publisher : Cambridge University Press Page : 128 pages File Size : 53,5 Mb Release : 2008-09-18 Category : Medical ISBN : 9781139473651
Essential Psychiatry by Robin M. Murray,Kenneth S. Kendler,Peter McGuffin,Simon Wessely,David J. Castle Pdf
This is a major international textbook for psychiatrists and other professionals working in the field of mental healthcare. With contributions from opinion-leaders from around the globe, this book will appeal to those in training as well as to those further along the career path seeking a comprehensive and up-to-date overview of effective clinical practice backed by research evidence. The book is divided into cohesive sections moving from coverage of the tools and skills of the trade, through descriptions of the major psychiatric disorders and on to consider special topics and issues surrounding service organization. The final important section provides a comprehensive review of treatments covering all of the major modalities. Previously established as the Essentials of Postgraduate Psychiatry, this new and completely revised edition is the only book to provide this depth and breadth of coverage in an accessible, yet authoritative manner.
Search for the Causes of Schizophrenia by W.F. Gattaz,H. Häfner Pdf
- The topics covered in the six sections of the book are Epidemiology and Environment, Precursors, Pathophysiological Mechanisms, Genetics, Controversies in Schizophrenia, and Treatment. - Reflects the progress made on Schizophrenia since 1986.
Author : Daniel R. Weinberger,Paul Harrison Publisher : John Wiley & Sons Page : 736 pages File Size : 49,6 Mb Release : 2011-07-13 Category : Medical ISBN : 9781444347746
Schizophrenia by Daniel R. Weinberger,Paul Harrison Pdf
Schizophrenia is one of the most complex and disabling diseases to affect mankind. Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it. However, in the past decade, there has been an explosion of new research, with dramatic discoveries involving genetic etiology and epidemiological risk factors. There has also been a catalog of new drugs coming to market, and controversy about the relative advantages and disadvantages of newer compared with older therapies. In addition, developing technologies in genomics, molecular biology and neuroimaging provide streams of new information. This book represents a definitive, essential, and up-to-date reference text on schizophrenia. It extensively and critically digests and clarifies recent advances and places them within a clinical context. The Editors (one American and one British), highly respected clinical psychiatrists and researchers and acknowledged experts on schizophrenia, have again assembled an outstanding group of contributors from the USA, UK, Europe and Australia, It will be of value to practising psychiatrists and to trainees, as well as to clinical and neuroscience researchers interested in keeping up with this field or coming into it. The book consists of four sections: descriptive aspects, biological aspects, physical treatments, and psychological and social aspects. It reviews the theoretical controversies over symptomatology, classification and aetiology (particularly pertinent as DSM-V is being developed), the relationship of schizophrenia to the other psychoses, the significance of positive and negative symptoms and pre-morbid personality. It describes a variety of approaches to integrating the vast research data about schizophrenia, including neurodevelopmental, genetic, pharmacological, brain imaging and psychological findings. The biological treatment section reviews the comparative efficacy of various drugs, the management of drug-resistant patients and both neurological and metabolic complications. The final section looks at psychological therapies, social outcomes, and the economics of schizophrenia. Highly Commended in the Psychiatry section of the 2012 BMA Book Awards.